Is Wegovy 0.5mg Stronger Than 0.25mg, and Does It Matter for You?

The real question: should you move up, or wait at 0.25mg?

Most people asking whether 0.5mg is stronger than 0.25mg are really asking a more personal question: is it the right moment to increase? That's a sensible thing to think about. The short answer is that 0.25mg was never designed to be a long-term dose. The NHS semaglutide medicines guide makes clear that the starting dose is a tolerability measure, giving your digestive system time to adapt to semaglutide before you reach doses where the appetite-regulating effect becomes more pronounced.

At 0.5mg you're getting twice the semaglutide per injection, and for most people that difference becomes noticeable: a stronger sense of fullness, reduced appetite, less interest in snacking between meals. It's also the first dose where you're in genuinely therapeutic territory. That said, "stronger" does not automatically mean "better right now". If nausea or other gastrointestinal effects were difficult in week one or two, your prescriber may recommend staying at 0.25mg a little longer before stepping up.

The practical question, then, isn't whether 0.5mg is technically the stronger dose (it is) but whether your body is ready for it. That's a clinical judgement, not one to make based on the calendar alone. Our prescribers at nume review this at every stage of treatment.

What changes at each step between 0.25mg and 0.5mg

Semaglutide works as a GLP-1 receptor agonist: it mimics the gut hormone GLP-1, slowing how quickly your stomach empties and signalling to your brain that you've eaten enough. At 0.25mg, you're activating those receptors, but at a level chosen more for comfort than effect. Clinical trial data — including the STEP 1 trial published in the New England Journal of Medicine — found average weight reduction of around 15% at 2.4mg over 68 weeks, but participants passed through 0.25mg and 0.5mg to get there. Neither starter dose contributes much to weight loss individually; they exist so that the full therapeutic doses are tolerable when you reach them.

Between 0.25mg and 0.5mg, you may notice that gastrointestinal effects are slightly more present: nausea, loose stools, or some indigestion are common in the first few days after stepping up, and they typically ease within a week or two. Injection sites, technique and timing all stay the same. If you want a broader picture of how all five doses compare, the Wegovy dose guide sets out the full schedule in one place.

One thing our prescribers hear fairly regularly: people who order just before a bank holiday worrying whether they'll be without their next dose during the step-up window. If your review falls around a holiday, raise it with us through aftercare in advance so there's no gap.

Side effects at 0.5mg versus 0.25mg: what to expect

The side-effect profile of Wegovy is well-established, and the pattern is consistent across dose increases: most effects are gastrointestinal, most are mild to moderate, and most settle as your body adjusts. Nausea tends to be the most commonly reported, followed by changes in bowel habit, some reflux, and occasional headache or fatigue. These effects are often more noticeable in the first few days after stepping from 0.25mg to 0.5mg than they were when you started the 0.25mg dose, simply because there's more semaglutide in your system.

More serious effects are uncommon but worth knowing. Acute pancreatitis is a recognised, if infrequent, risk with GLP-1 medicines. Severe stomach pain that radiates toward your back, with or without vomiting, warrants urgent medical attention. The MHRA has highlighted this in formal safety guidance for GLP-1 medicines, and any suspected side effect can be reported at the Yellow Card scheme. If you experience anything that concerns you between doses, our aftercare team is available seven days a week.

For a closer look at how the effect of 0.5mg specifically compares with higher doses, the guide to whether 0.5mg Wegovy is strong enough covers that in detail.

How the titration decision is made in practice

Wegovy is a prescription-only medicine, which means the titration schedule isn't self-directed. Your prescriber reviews your response before each dose increase: how your body has tolerated the current dose, whether you've had meaningful side effects, and how your weight and general health are progressing. This is why the roughly four-week steps exist: they give enough time to gather useful signal before making a change.

At 0.5mg, you're at the beginning of the therapeutic range, not the end. The full schedule continues through 1mg and 1.7mg before reaching the 2.4mg maintenance dose. It's also worth knowing that following the 2024 MHRA approval of a 7.2mg option for eligible adults, the licensed ceiling has extended further for some patients, the details on the higher-dose approval explain what that means and who it applies to.

If you're considering starting Wegovy and want to understand how private treatment works, the Wegovy overview covers eligibility and the consultation process. Thinking about what treatment might cost? The Wegovy pricing page sets out the context honestly. When you're ready to talk through your own situation with a prescriber, you can check your eligibility for a free consultation with no obligation.